C12N 2760/20261
Methods of inactivation or attenuation
C12N2760/20261 (Methods of inactivation or attenuation) appears on 56 US grants and 45 published applications in this corpus.
Search patents in C12N- Granted patents
- 56
- Published applications
- 45
- Assignees
- 36
- Inventors
- 117
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 1 |
| 2002 | 2 | 1 |
| 2003 | 4 | 2 |
| 2004 | 1 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 2 |
| 2008 | 1 | 0 |
| 2009 | 0 | 4 |
| 2010 | 1 | 1 |
| 2011 | 1 | 0 |
| 2012 | 2 | 2 |
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 1 | 2 |
| 2016 | 0 | 0 |
| 2017 | 4 | 4 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 4 |
| 2022 | 0 | 0 |
| 2023 | 2 | 1 |
| 2024 | 2 | 6 |
| 2025 | 6 | 5 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Oncolytic virus in combination with immune checkpoint inhibitor for treating tumors15 Sep 2026US 12,734,202 B2Joint Biosciences (Sh) Ltd.
- Mutated glycoprotein of vesicular stomatitis virus9 Sep 2025US 12,410,215 B2Centre National de la Recherche Scientifique (CNRS)
- Mutated glycoprotein of vesicular stomatitis virus9 Sep 2025US 12,410,216 B2Centre National de la Recherche Scientifique (CNRS)
- Mutated glycoprotein of vesicular stomatitis virus13 May 2025US 12,297,237 B2Centre National de la Recherche Scientifique (CNRS)
- Mutated glycoprotein of vesicular stomatitis virus6 May 2025US 12,291,551 B2Centre National de la Recherche Scientifique (CNRS)
- Mutated Glycoprotein of Vesicular Stomatitis Virus19 Mar 2026US 2026/0078150 A1Centre National de la Recherche Scientifique (CNRS)
- Recombinant Viral Genomes and Related Compositions and Methods24 Jul 2025US 2025/0235493 A1
- Morreton viruses and methods of use19 Jun 2025US 2025/0195591 A1Mayo Foundation for Medical Education and Research
- Recombinant viral vector and uses thereof12 Jun 2025US 2025/0188493 A1University of Miami
- Mutated Glycoprotein of Vesicular Stomatitis Virus29 May 2025US 2025/0171504 A1Centre National de la Recherche Scientifique (CNRS)
Most cited
By later US patents
- Photodynamic inactivation of viruses in blood cell-containing compositions94US 5,120,649 ANew York Blood Center, Inc. · 1992
- Preparation of inactivated viral vaccines92US 4,693,981 AAdvanced Genetics Research Institute · 1987
- Photodynamic inactivation of viruses in cell-containing compositions80US 5,232,844 ANew York Blood Center, Inc. · 1993
- Processes for photoreactive inactivation of a virus in blood cell or coagulation factor containing compositions and use thereof for preparing compositions useful for transfusion71US 6,294,361 B1New York Blood Center, Inc. · 2001
- Inactivation of viruses in labile blood derivatives64US 4,613,501 ANew York Blood Center, Inc. · 1986